Atossa Therapeutics (YAG2.F) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.91
-0.62
-0.33
-0.04

Details

Expected EPS
-0.841035
Actual EPS
-0.90573
Surprise EPS
-0.06
Surprise Percent
+7.69%

Description

Atossa Therapeutics (YAG2.F) has reported earnings of -0.90573 per share for Q4 2025.

0 Comments

Share your thoughts